Instadose Pharma Corp. entered into a non-binding letter of intent to acquire Mikrocoze Inc. (OTCPK:MZKR) for $0.03 million in a reverse merger transaction on December 7, 2020. Instadose Pharma Corp. entered into a definitive agreement to acquire Mikrocoze Inc. (OTCPK:MZKR) in a reverse merger transaction on September 1, 2021. Post acquisition 80% of the issued and outstanding shares of common stock of the Mikrocoze will be held by Instadose Pharma. Post-completion, Mikrocoze shall effect an increase in the authorized shares and a name change to the name selected by the shareholders. Upon consummation of the transaction, Grant Sanders will be Chief Executive Officer and Director, Larry Acton will be Chief Operating Officer and Director, Loren Greenspoon will be Chief Legal Counsel, Geoff Belsher and Terry Wilshire will be Directors of Mikrocoze. The transaction is subject to number of conditions, including but not limited to, approval of the acquisition by the shareholders of the Mikrocoze and Instadose, obtaining necessary regulatory, third party approvals, due diligence, definitive agreement and no material adverse change occurring in the Mikrocoze or Instadose. As of October 19, 2021, the transaction was approved by Supreme Court of British Columbia. The transaction is expected to close no later than 90 days after the execution of the definitive transaction documents subject to extension by the parties. On April 29, 2021, Instadose Pharma entered into an amendment to the LOI, The Amendment amends the exclusivity period prescribed in the LOI, extending such period until the earlier to occur of (i) either Party terminating the LOI and the proposed transaction providing notice to the other party, (ii) the consummation of the contemplated transaction, and (iii) July 31, 2021. The Crone Law Group acted as legal advisor to Mikrocoze and Gowling WLG (Canada) LLP acted as legal advisor to Instadose. IJW & Co., Ltd. acted as financial advisor and fairness opinion provider to Instadose.


Instadose Pharma Corp. completed the acquisition of Mikrocoze Inc. (OTCPK:MZKR) in a reverse merger transaction on December 31, 2021.